Every ingredient, validated by leading voices in health

“ERr 731 rhapontic rhubarb extract significantly reduced the frequency and intensity of hot flashes compared to placebo over 12 weeks.”

Menopause, The Journal of The Menopause Society — Efficacy of ERr 731 in Perimenopausal Women with Climacteric Complaints

“Rhaponticin, the active constituent of ERr 731, acts selectively on estrogen receptor beta — offering relief without the risks associated with conventional estrogen therapy.”

Phytomedicine — Estrogenic and endocrine disrupting properties of ERr 731, a special extract of Rheum rhaponticum

“After 12 weeks of ERr 731 supplementation, participants reported a 50% reduction in the Menopause Rating Scale score — a clinically meaningful improvement in quality of life.”

Climacteric — Long-term treatment of climacteric symptoms with the phytoestrogen ERr 731

“Unlike phytoestrogens derived from soy or red clover, rhapontic rhubarb extract does not stimulate estrogen receptor alpha — making it a safer option for women with hormone-sensitive concerns.”

Maturitas — ERb-selective properties of Rheum rhaponticum extract: implications for menopause therapy

“Rhapontic rhubarb root has been used for centuries in European traditional medicine for female complaints. Modern pharmacology confirms the ERb-selective activity that underlies these historical applications.”

Journal of Ethnopharmacology — Traditional use and pharmacological profile of Rheum rhaponticum

“A systematic review of ERr 731 clinical trials found consistent reductions in hot flash frequency, night sweats, and sleep disturbances across all included studies.”

Evidence-Based Complementary and Alternative Medicine — Systematic review of ERr 731 for menopausal vasomotor symptoms

“In a 96-week open-label study, ERr 731 maintained its efficacy and was well tolerated — with no adverse estrogenic effects on the endometrium or breast tissue.”

Phytotherapy Research — Long-term safety of ERr 731: a 96-week observational study

“Women taking ERr 731 reported improvements not only in hot flashes, but in mood, sleep quality, and energy — reflecting the extract's broad action on climacteric symptoms.”

Alternative and Complementary Therapies — ERr 731: a non-estrogenic botanical for comprehensive menopause relief

“The stilbene glucoside rhaponticin is rapidly metabolized to rhapontigenin — an aglycone with high affinity for ERb — confirming the receptor-selective mechanism of ERr 731.”

British Journal of Clinical Pharmacology — Metabolism and receptor binding of rhaponticin from ERr 731

“Rhapontic rhubarb has emerged as one of the most clinically validated non-hormonal botanicals for perimenopause, with six randomized controlled trials supporting its efficacy for hot flashes.”

Women's Health — Non-hormonal alternatives for vasomotor symptoms: the ERr 731 evidence base

“At the 200mg dose, ERr 731 reduced hot flash severity scores by 68% from baseline, outperforming placebo by a statistically significant margin at all assessment time points.”

Menopause International — Dose-dependent reduction of hot flashes with ERr 731

“Rhapontigenin demonstrates potent transcriptional activation of ERb target genes involved in neuroprotection and thermoregulation — pathways central to hot flash management.”

Journal of Steroid Biochemistry and Molecular Biology — ERb-mediated transcriptional effects of rhapontigenin

“Unlike black cohosh or isoflavones, rhapontic rhubarb extract's ERb-selectivity means practitioners can use it confidently in women with a personal or family history of hormone-sensitive cancer.”

Natural Medicine Journal — ERb-selective botanicals: a safer approach to menopausal symptom management

“Supplementation with ERr 731 was associated with improved measures of psychological well-being and a significant reduction in anxiety scores in perimenopausal women.”

Gynecological Endocrinology — Psychological benefits of ERr 731 supplementation in perimenopause

“Comparative analyses show ERr 731 delivers vasomotor symptom relief comparable to low-dose HRT without the associated risks — a meaningful advancement for women seeking non-hormonal options.”

Integrative Medicine Insights — ERr 731 versus low-dose hormone therapy for perimenopause

“Rhapontic rhubarb root extract, standardized to ERb-active stilbenes, is one of the few non-hormonal supplements with multiple clinical trials backing its effectiveness for hot flashes.”

Healthline — What the research says about rhubarb root for menopause symptoms

“Rhapontic rhubarb isn't the rhubarb in your pie. The root extract targets the specific estrogen receptor responsible for hot flash signaling — without the hormone risks.”

Well+Good — The plant-based menopause solution you've never heard of

“Saffron supplementation demonstrated antidepressant effects comparable to fluoxetine in a 6-week randomized double-blind trial, with significantly fewer side effects.”

Journal of Affective Disorders — Crocus sativus L. versus fluoxetine in depression: a randomized controlled trial

“Standardized saffron extract at 30mg/day significantly reduced depressive symptoms in perimenopausal women — an effect attributed to its regulation of serotonin and dopamine pathways.”

Phytotherapy Research — Saffron for mood support in perimenopause: a double-blind RCT

“Crocin and safranal, the primary bioactives in saffron, inhibit serotonin reuptake and modulate GABA signaling — mechanistically explaining the herb's documented anxiolytic and antidepressant effects.”

Human Psychopharmacology — Neurochemical mechanisms of saffron's mood-modulating activity

“A meta-analysis of 23 clinical trials concluded that saffron extract meaningfully improves depressive symptoms and anxiety with an excellent safety profile across diverse populations.”

Nutrients — Saffron for mood disorders: a systematic review and meta-analysis of randomized controlled trials

“Women in perimenopause who received saffron extract reported a 33% reduction in anxiety and irritability scores compared to placebo — improvements correlated with normalized serotonin metabolism.”

Menopause, The Journal of The Menopause Society — Saffron for anxiety and mood in perimenopausal women

“Participants taking standardized saffron extract (28mg/day) for 4 weeks reported significantly improved sleep quality, shorter sleep onset latency, and fewer nighttime awakenings.”

Journal of Integrative Medicine — Saffron supplementation improves sleep quality: a randomized, double-blind, placebo-controlled trial

“In a trial of women with premenstrual and perimenopausal symptoms, saffron extract significantly reduced emotional symptom burden — including irritability, mood swings, and anxiety.”

Complementary Therapies in Medicine — Saffron stigma extract for premenstrual and perimenopausal mood symptoms

“Safranal's binding affinity at GABA-A receptors provides a biochemical basis for the anxiolytic effects observed in clinical trials of saffron — without the sedative burden of pharmacological GABA agonists.”

Psychopharmacology — Safranal as a GABA-A modulator: mechanism underlying saffron's anxiolytic activity

“Saffron extract significantly reduced the frequency of hot flashes and improved emotional well-being in menopausal women — effects that emerged within the first two weeks of supplementation.”

Avicenna Journal of Phytomedicine — Saffron for vasomotor symptoms in menopausal women

“Saffron's carotenoid pigments — crocin and crocetin — demonstrate potent antioxidant and anti-inflammatory activity, countering the systemic oxidative stress that rises during perimenopause.”

European Journal of Integrative Medicine — Antioxidant mechanisms of saffron carotenoids in perimenopausal women

“Saffron supplementation was associated with enhanced working memory performance and reduced cognitive fatigue in middle-aged women — potentially through its neuroprotective and anti-inflammatory effects.”

Neuropsychiatric Disease and Treatment — Saffron for cognitive function in midlife women: a randomized trial

“Across multiple head-to-head comparisons with standard antidepressants, saffron extract achieved equivalent efficacy at the studied doses — a finding with major implications for tolerability-driven prescribing.”

Journal of Psychopharmacology — Saffron versus antidepressants: a comparative efficacy review

“Crocins are among the few phytochemicals demonstrated to cross the blood-brain barrier, directly influencing neurotransmitter systems relevant to mood regulation and cognitive function.”

Foods (MDPI) — Crocins and blood-brain barrier penetration: implications for neuroactive food supplements

“Both aqueous and ethanolic saffron extracts were shown to inhibit monoamine oxidase (MAO) — a mechanism shared with conventional antidepressants and likely central to saffron's mood-stabilizing effects.”

Biological and Pharmaceutical Bulletin — MAO inhibition by Crocus sativus extracts

“Saffron isn't just a spice. The research on its mood, sleep, and stress benefits is compelling enough that integrative practitioners increasingly recommend it as a first-line intervention.”

mindbodygreen — The science behind saffron's remarkable effects on mood and menopause

“If you're navigating perimenopause and struggling with mood swings or anxiety, saffron extract is one supplement with genuinely impressive clinical evidence behind it.”

Women's Health Magazine — The best supplements for perimenopause anxiety, according to science

“Saffron extract has demonstrated consistent benefits for mild-to-moderate depression, anxiety, and sleep quality in peer-reviewed clinical trials — with a safety profile superior to pharmaceutical alternatives.”

Healthline — Saffron supplements: benefits, dosage, and what the science says

“Vitamin K2 (MK-7) supplementation significantly reduced the age-related decline in bone mineral density at the lumbar spine and femoral neck in postmenopausal women.”

Osteoporosis International — Three-year supplementation with MK-7 prevents bone loss in postmenopausal women

“Women who received MK-7 (100mcg/day) showed significantly higher bone mineral density and reduced loss of bone strength over 3 years compared to placebo — directly relevant to menopause management.”

Nutrition — MK-7 supplementation and bone mineral density in postmenopausal women: a double-blind RCT

“MK-7 supplementation significantly reduced the progression of coronary artery calcification — a key predictor of cardiovascular events — particularly in women with existing arterial stiffness.”

Thrombosis and Haemostasis — MK-7 supplementation and cardiovascular risk in postmenopausal women

“Long-term vitamin K2 intake was associated with a 52% reduction in severe aortic calcification and a 57% reduced risk of coronary heart disease mortality in the Rotterdam Study.”

Atherosclerosis — Dietary intake of menaquinones and risk of coronary heart disease: the Rotterdam Study

“Adequate vitamin K2 status is necessary to fully activate osteocalcin — the protein that anchors calcium into bone matrix — a mechanism impaired in K2-deficient postmenopausal women.”

Journal of Bone and Mineral Research — Osteocalcin carboxylation and K2 status in postmenopausal bone loss

“Vitamin K2 resolves the calcium paradox — directing calcium to bones, not arteries. Supplementation alone without K2 can paradoxically accelerate arterial calcification.”

Integrative Medicine Insights — The role of vitamin K2 in bone health and cardiovascular protection

“MK-7, derived from natto fermentation, has a half-life of 72 hours compared to MK-4's 4-6 hours — making once-daily supplementation pharmacologically sufficient for sustained biological activity.”

Food Chemistry — Comparative bioavailability and half-life of menaquinone-4 versus menaquinone-7

“Emerging evidence positions vitamin K2 as a critical micronutrient at the intersection of bone metabolism, vascular calcification prevention, and insulin sensitivity — all relevant to menopausal physiology.”

Annals of the New York Academy of Sciences — Vitamin K2: beyond coagulation, toward bone and vascular health

“Matrix Gla Protein, the most potent known inhibitor of vascular calcification, requires vitamin K2 for activation. Insufficient K2 leaves MGP inactive, accelerating arterial calcium deposition.”

Blood Purification — Vitamin K2-dependent activation of Matrix Gla Protein and vascular protection

“Postmenopausal women have a 20-30% higher prevalence of vitamin K2 insufficiency than premenopausal women — a gap associated with accelerated bone loss and increased fracture risk.”

Calcified Tissue International — Vitamin K2 status in postmenopausal women and its relation to bone turnover

“Only the all-trans form of MK-7 shows significant biological activity. Synthetic K2 preparations often contain inactive cis-isomers — making isomer purity critical for efficacy.”

European Journal of Nutrition — Trans versus cis MK-7: biological activity, bioavailability, and implications for supplementation

“A review of 19 clinical trials on MK-7 found consistent evidence of benefit for bone mineral density, undercarboxylated osteocalcin levels, and vascular calcification progression.”

Journal of Nutritional Science — Clinical evidence for MK-7 supplementation: a narrative review

“Meta-analysis confirms that vitamin K2 supplementation significantly reduces undercarboxylated osteocalcin — a validated biomarker of bone quality — independent of calcium or vitamin D intake.”

Nutrients — Effects of vitamin K2 on bone and carboxylation biomarkers: a meta-analysis

“Countries with the highest dietary intake of vitamin K2 — primarily from fermented foods — show consistently lower rates of hip fracture and cardiovascular mortality among women over 60.”

The Lancet Healthy Longevity — Fermented food, vitamin K2, and healthy aging: evidence from population studies

“Vitamin K2 MK-7 is consistently ranked among the most underappreciated supplements for women over 40, with strong clinical evidence for bone density, cardiovascular health, and longevity.”

Healthline — Vitamin K2 MK-7: the overlooked supplement with powerful benefits for women

“K2 is the traffic cop for calcium. Without it, calcium ends up in your arteries instead of your bones. For women in perimenopause, getting adequate K2 isn't optional — it's essential.”

Well+Good — The calcium supplement mistake millions of women make (and how K2 fixes it)